Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-023134
Filing Date
2019-11-18
Accepted
2019-11-18 17:03:50
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20190930_10q.htm 10-Q 738403
2 EXHIBIT 31.1 ex_165148.htm EX-31.1 9485
3 EXHIBIT 31.2 ex_165149.htm EX-31.2 9628
4 EXHIBIT 32.1 ex_165150.htm EX-32.1 4216
5 EXHIBIT 32.2 ex_165151.htm EX-32.2 4205
  Complete submission text file 0001437749-19-023134.txt   4868353

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20190930.xml EX-101.INS 962935
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20190930.xsd EX-101.SCH 67649
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20190930_cal.xml EX-101.CAL 31966
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20190930_def.xml EX-101.DEF 430881
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20190930_lab.xml EX-101.LAB 320919
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20190930_pre.xml EX-101.PRE 454717
Mailing Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2
Business Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 191228219
SIC: 2834 Pharmaceutical Preparations